Cargando…
Synergistic Inhibition of Sars-Coronavirus Replication by Type I and Type II IFN
Autores principales: | Mossel, Eric C., Sainz, Bruno, Garry, Robert F., Peters, C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123288/ https://www.ncbi.nlm.nih.gov/pubmed/17037585 http://dx.doi.org/10.1007/978-0-387-33012-9_89 |
Ejemplares similares
-
Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
por: Sainz, Bruno, et al.
Publicado: (2004) -
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
por: Sainz, Bruno, et al.
Publicado: (2006) -
SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells
por: Mossel, Eric C., et al.
Publicado: (2008) -
P136 Combined action of type I and type III IFN restricts initial replication of SARS-coronavirus in the lung but fails to inhibit systemic virus spread
por: Mahlakoiv, T., et al.
Publicado: (2012) -
Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)